Mesenchymal stem cell (MSC)‐derived EVs highly express fibroblast growth factor 19 (FGF19) which promotes NPC cell proliferation and metastasis through activating FGF19‐FGFR4‐dependent ERK signaling and by regulating EMT. The gene discussed is FGF19; the disease is nasopharyngeal carcinoma.